Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × Lymph Node Excision × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Endometrial Neoplasms 7 Lymphatic Metastasis 6 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 3 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Postoperative Complications 2 Ovarian Neoplasms 2 Lymphedema 2 Lung Neoplasms 2 Clinical Stage I Gastric Cancer AJCC v8 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Ureteral Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Radiation Injuries 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Platelet Glycoprotein IV Deficiency 1 Parotid Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm Metastasis 1 Mixed Tumor, Mesodermal 1 Melanoma 1 Facies 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Gemcitabine 95 Cisplatin 63 Oxaliplatin 40 pembrolizumab 30 Fluorouracil 29 Capecitabine 29 durvalumab 25 lenvatinib 24 Leucovorin 23 Radiofrequency Ablation 11 Nivolumab 11 Magnetic Resonance Spectroscopy 11 Irinotecan 11 Drug Therapy 11 apatinib 10 Radiotherapy 10 pemigatinib 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Taxes 8 Specimen Handling 8 Folfox protocol 8 Floxuridine 8 Biopsy 8 Bevacizumab 8 tremelimumab 7 Liver Transplantation 7 Cholangiopancreatography, Endoscopic Retrograde 7 Carboplatin 7 130-nm albumin-bound paclitaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03796819 2021-12-09

LND for ICC

First Affiliated Hospital Xi'an Jiaotong University

Phase NA Completed

Gastrointestinal

Lymphatic Metastasis, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡